Fabiana Letizia Cecere

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy

Joaquim Bellmunt, Luis Paz‐Ares, Mauricio Cuello et al. · Annals of Oncology · 2007 · 315 citations · Full text

Urology, Oncology, Cisplatin-based Chemotherapy +9

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

R. de las Peñas, M. Sánchez-Ronco, Vicente Alberola et al. · Annals of Oncology · 2006 · 171 citations · Full text

Chromatin, Genome Instability, Dna Repair Genes +10

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 145 citations · Full text

First-line Pembrolizumab, Medicine, Pathology +6

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

Quincy S. Chu, Laurent Greillier, Wei Tu et al. · The Lancet · 2023 · 86 citations

Chemotherapy Versus Chemotherapy, Oncology, Pathology +5

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer

Emilio Bria, Michèle Milella, Isabella Sperduti et al. · Lung Cancer · 2009 · 84 citations

Prognostic Evaluation, Prognostic Biomarkers, Surgical Oncology +12